IHC ER+PR+HER2NEU+KI67 Test
Short Name: IHC ER PR HER2NEU KI67
Also known as: Breast Cancer IHC Panel, ER PR HER2 KI67 Test, Hormone Receptor Test
IHC ER+PR+HER2NEU+KI67 Test test available at DNA Labs India for ₹9,000. Uses Immunohistochemistry on Tissue samples. Results in 6 days. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr Pasupathy Arumugam
Consultant Pathologist · Reg: 21521
Last reviewed: September 7, 2026
Overview
To diagnose breast cancer and determine receptor status (ER, PR, HER2NEU) and proliferation rate (Ki67) for personalized treatment planning.
- Test Code
- 3055
- Price
- ₹9,000
- Sample Type
- Tissue
- Result Time
- 6 days
- Fasting Required
- No
- Method
- Immunohistochemistry
Sample Collection
Consult with a doctor for prescription. No specific preparation needed.
Method: Biopsy
Laboratory Analysis
Biopsy procedure performed by a healthcare professional to obtain tissue sample.
Report Delivery
Sample is fixed in 10% neutral buffered formalin and sent to the lab for analysis.
Timeline: 6 days
Patient Instructions
About This Test
Who Should Get This Test
To diagnose breast cancer and determine receptor status (ER, PR, HER2NEU) and proliferation rate (Ki67) for personalized treatment planning.
How to Prepare
- Ensure tissue is fixed in 10% neutral buffered formalin
- Label sample with patient details
- Transport sample at ambient temperature
Doctor's Notes
Reviewed by Dr Pasupathy Arumugam — MBBS, MD (Pathology) · Reg. No. 21521
"This test is crucial for determining breast cancer subtypes and guiding treatment decisions, such as hormonal or targeted therapy."
Last medically reviewed: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Inadequate sample size
- Improper fixation
- Contaminated sample
Understanding Your Results
ER/PR Positive
Hormone receptor-positive breast cancer, may benefit from hormonal therapy.
HER2NEU Positive (Score 3+)
HER2-positive breast cancer, may benefit from targeted therapy.
High Ki67 (≥14%)
High proliferation rate, indicating more aggressive cancer.
All Negative
Triple-negative breast cancer, may require chemotherapy.
If symptoms persist, results are abnormal, or for treatment planning based on test outcomes.
Limitations
- ⚠Not a standalone diagnostic tool
- ⚠Requires biopsy sample
- ⚠Results may vary based on tissue quality
Risks & Considerations
- ●Biopsy risks: minor bleeding, infection, or discomfort
Interfering Factors
- ●Tissue fixation issues
- ●Sample degradation
- ●Improper staining techniques
Compare With Similar Tests
| Test | IHC ER+PR+HER2NEU+KI67 | |||
|---|---|---|---|---|
| Comparison | IHC ER+PR+HER2NEU+KI67 |
Frequently Asked Questions
What is the IHC ER+PR+HER2NEU+KI67 test?
What is the cost of this test at DNA Labs India?
How is the test performed?
What does the test measure?
Who should get this test?
How long does it take to get results?
Is home sample collection available?
What are the symptoms that may require this test?
How accurate is the test?
What do positive or negative results mean?
Are there any risks associated with the test?
How can I book this test?
Related Tests
Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.